Trial Profile
A Ten-Week, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of Milnacipran for Radicular Pain Associated With Lumbosacral Disk Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Musculoskeletal pain; Sciatica
- Focus Therapeutic Use
- 05 Feb 2013 New trial record